Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Noble Biomaterials revenue
Noble Biomaterials's revenue is $22.0 million.
What is Noble Biomaterials's revenue?
- Noble Biomaterials has 100 employees, and the revenue per employee ratio is $220,000.
- Noble Biomaterials peak revenue was $22.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Noble Biomaterials financing
Noble Biomaterials received early financing of $8.0M on 2012-02-10.
| Series | Round size | Date |
|---|---|---|
| Series B | $8M | 02/2012 |
| Grant | $25K | 06/2020 |
Noble Biomaterials investors
| Investors | Security type |
|---|---|
| DuPont Capital Management | Series B |
| TL Ventures | Series B |
| Northwater Capital | Series B |
| Ben Franklin Technology Partners of Northeastern Pennsylvania | Grant |
Noble Biomaterials competitors
Noble Biomaterials's top competitor, STAAR® Surgical Co, earned an annual revenue of $313.9M.
Noble Biomaterials's smallest competitor is SynCardia with revenue of $6.8M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Corindus Vascular Robotics | - | $10.8M | 90 | - |
| Sciessent | - | $8.4M | 20 | - |
| Adhezion Biomedical | - | $12.3M | 40 | - |
| MTS Medication Technologies, Inc. | - | $81.6M | 200 | - |
| STAAR® Surgical Co | - | $313.9M | 806 | - |
| SynCardia | - | $6.8M | 66 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Noble Biomaterials, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Noble Biomaterials. The employee data is based on information from people who have self-reported their past or current employments at Noble Biomaterials. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Noble Biomaterials. The data presented on this page does not represent the view of Noble Biomaterials and its employees or that of Zippia.
Noble Biomaterials may also be known as or be related to Noble Biomaterials.